Literature DB >> 21993686

Analysis of NOTCH1 mutations in monoclonal B-cell lymphocytosis.

Silvia Rasi, Sara Monti, Valeria Spina, Robin Foà, Gianluca Gaidano, Davide Rossi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21993686      PMCID： PMC3248947          DOI： 10.3324/haematol.2011.053090

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL.

Authors:  Paolo Sportoletti; Stefano Baldoni; Laura Cavalli; Beatrice Del Papa; Elisabetta Bonifacio; Raffaella Ciurnelli; Alain Sylvin Bell; Ambra Di Tommaso; Emanuela Rosati; Barbara Crescenzi; Cristina Mecucci; Isabella Screpanti; Pierfrancesco Marconi; Massimo F Martelli; Mauro Di Ianni; Franca Falzetti
Journal:  Br J Haematol       Date:  2010-08-31       Impact factor: 6.998

2.  The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.

Authors:  Davide Rossi; Elisa Sozzi; Alessia Puma; Lorenzo De Paoli; Silvia Rasi; Valeria Spina; Alessandro Gozzetti; Maristella Tassi; Emanuele Cencini; Donatella Raspadori; Valeria Pinto; Francesco Bertoni; Valter Gattei; Francesco Lauria; Gianluca Gaidano; Francesco Forconi
Journal:  Br J Haematol       Date:  2009-05-05       Impact factor: 6.998

Review 3.  Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management.

Authors:  T D Shanafelt; P Ghia; M C Lanasa; O Landgren; A C Rawstron
Journal:  Leukemia       Date:  2010-01-21       Impact factor: 11.528

4.  A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation.

Authors:  Mauro Di Ianni; Stefano Baldoni; Emanuela Rosati; Raffaella Ciurnelli; Laura Cavalli; Massimo F Martelli; PierFrancesco Marconi; Isabella Screpanti; Franca Falzetti
Journal:  Br J Haematol       Date:  2009-07-10       Impact factor: 6.998

5.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.

Authors:  Xose S Puente; Magda Pinyol; Víctor Quesada; Laura Conde; Gonzalo R Ordóñez; Neus Villamor; Georgia Escaramis; Pedro Jares; Sílvia Beà; Marcos González-Díaz; Laia Bassaganyas; Tycho Baumann; Manel Juan; Mónica López-Guerra; Dolors Colomer; José M C Tubío; Cristina López; Alba Navarro; Cristian Tornador; Marta Aymerich; María Rozman; Jesús M Hernández; Diana A Puente; José M P Freije; Gloria Velasco; Ana Gutiérrez-Fernández; Dolors Costa; Anna Carrió; Sara Guijarro; Anna Enjuanes; Lluís Hernández; Jordi Yagüe; Pilar Nicolás; Carlos M Romeo-Casabona; Heinz Himmelbauer; Ester Castillo; Juliane C Dohm; Silvia de Sanjosé; Miguel A Piris; Enrique de Alava; Jesús San Miguel; Romina Royo; Josep L Gelpí; David Torrents; Modesto Orozco; David G Pisano; Alfonso Valencia; Roderic Guigó; Mónica Bayés; Simon Heath; Marta Gut; Peter Klatt; John Marshall; Keiran Raine; Lucy A Stebbings; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Ivo Gut; Armando López-Guillermo; Xavier Estivill; Emili Montserrat; Carlos López-Otín; Elías Campo
Journal:  Nature       Date:  2011-06-05       Impact factor: 49.962

6.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

Authors:  E Joanna Baxter; Linda M Scott; Peter J Campbell; Clare East; Nasios Fourouclas; Soheila Swanton; George S Vassiliou; Anthony J Bench; Elaine M Boyd; Natasha Curtin; Mike A Scott; Wendy N Erber; Anthony R Green
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

7.  Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.

Authors:  Andy C Rawstron; Fiona L Bennett; Sheila J M O'Connor; Marwan Kwok; James A L Fenton; Marieth Plummer; Ruth de Tute; Roger G Owen; Stephen J Richards; Andrew S Jack; Peter Hillmen
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

8.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

9.  Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells.

Authors:  Emanuela Rosati; Rita Sabatini; Giuliana Rampino; Antonio Tabilio; Mauro Di Ianni; Katia Fettucciari; Andrea Bartoli; Stefano Coaccioli; Isabella Screpanti; Pierfrancesco Marconi
Journal:  Blood       Date:  2008-09-16       Impact factor: 22.113

10.  Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.

Authors:  Giulia Fabbri; Silvia Rasi; Davide Rossi; Vladimir Trifonov; Hossein Khiabanian; Jing Ma; Adina Grunn; Marco Fangazio; Daniela Capello; Sara Monti; Stefania Cresta; Ernesto Gargiulo; Francesco Forconi; Anna Guarini; Luca Arcaini; Marco Paulli; Luca Laurenti; Luigi M Larocca; Roberto Marasca; Valter Gattei; David Oscier; Francesco Bertoni; Charles G Mullighan; Robin Foá; Laura Pasqualucci; Raul Rabadan; Riccardo Dalla-Favera; Gianluca Gaidano
Journal:  J Exp Med       Date:  2011-06-13       Impact factor: 14.307
View more
  14 in total

1.  ATM and chronic lymphocytic leukemia: mutations, and not only deletions, matter.

Authors:  Davide Rossi; Gianluca Gaidano
Journal:  Haematologica       Date:  2012-01       Impact factor: 9.941

Review 2.  The double-edged sword of Notch signaling in cancer.

Authors:  Andrew P South; Raymond J Cho; Jon C Aster
Journal:  Semin Cell Dev Biol       Date:  2012-01-30       Impact factor: 7.727

Review 3.  The molecular pathogenesis of chronic lymphocytic leukaemia.

Authors:  Giulia Fabbri; Riccardo Dalla-Favera
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

4.  A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).

Authors:  Stefano Molica; Diana Giannarelli; Luciano Levato; Rosanna Mirabelli; Massimo Gentile; Mirella Lentini; Fortunato Morabito
Journal:  Int J Hematol       Date:  2014-07-27       Impact factor: 2.490

Review 5.  Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.

Authors:  Paolo Strati; Tait D Shanafelt
Journal:  Blood       Date:  2015-06-11       Impact factor: 22.113

Review 6.  Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.

Authors:  Lesley-Ann Sutton; Richard Rosenquist
Journal:  Haematologica       Date:  2015-01       Impact factor: 9.941

7.  Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index.

Authors:  Geffen Kleinstern; Daniel R O'Brien; Xing Li; Shulan Tian; Brian F Kabat; Kari G Rabe; Aaron D Norman; Huihuang Yan; Celine M Vachon; Nicholas J Boddicker; Timothy G Call; Sameer A Parikh; Laura Bruins; Cecilia Bonolo de Campos; Jose F Leis; Tait D Shanafelt; Wei Ding; James R Cerhan; Neil E Kay; Susan L Slager; Esteban Braggio
Journal:  Am J Hematol       Date:  2020-05-07       Impact factor: 10.047

Review 8.  Molecular pathogenesis of chronic lymphocytic leukemia.

Authors:  Gianluca Gaidano; Robin Foà; Riccardo Dalla-Favera
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

9.  Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.

Authors:  J Ojha; C Secreto; K Rabe; J Ayres-Silva; R Tschumper; D V Dyke; S Slager; R Fonseca; T Shanafelt; N Kay; E Braggio
Journal:  Leukemia       Date:  2014-07-18       Impact factor: 11.528

Review 10.  Clinical implications of the molecular genetics of chronic lymphocytic leukemia.

Authors:  Robin Foà; Ilaria Del Giudice; Anna Guarini; Davide Rossi; Gianluca Gaidano
Journal:  Haematologica       Date:  2013-05       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.